Display options
Share it on

Sci Rep. 2016 Sep 27;6:33779. doi: 10.1038/srep33779.

SMAR1 binds to T(C/G) repeat and inhibits tumor progression by regulating miR-371-373 cluster.

Scientific reports

Jinumary Mathai, Smriti P K Mittal, Aftab Alam, Payal Ranade, Devraj Mogare, Sonal Patel, Smita Saxena, Suvankar Ghorai, Abhijeet P Kulkarni, Samit Chattopadhyay

Affiliations

  1. Chromatin and Disease Biology Lab, National Centre for Cell Science, Savitribai Phule Pune University Campus, Ganeshkhind, Pune-411007, India.
  2. Department of Zoology, Savitribai Phule Pune University Campus, Pune 411007, India.
  3. Bioinformatics Centre, Savitribai Phule Pune University Campus, Pune 411007, India.

PMID: 27671416 PMCID: PMC5037395 DOI: 10.1038/srep33779

Abstract

Chromatin architecture and dynamics are regulated by various histone and non-histone proteins. The matrix attachment region binding proteins (MARBPs) play a central role in chromatin organization and function through numerous regulatory proteins. In the present study, we demonstrate that nuclear matrix protein SMAR1 orchestrates global gene regulation as determined by massively parallel ChIP-sequencing. The study revealed that SMAR1 binds to T(C/G) repeat and targets genes involved in diverse biological pathways. We observe that SMAR1 binds and targets distinctly different genes based on the availability of p53. Our data suggest that SMAR1 binds and regulates one of the imperative microRNA clusters in cancer and metastasis, miR-371-373. It negatively regulates miR-371-373 transcription as confirmed by SMAR1 overexpression and knockdown studies. Further, deletion studies indicate that a ~200 bp region in the miR-371-373 promoter is necessary for SMAR1 binding and transcriptional repression. Recruitment of HDAC1/mSin3A complex by SMAR1, concomitant with alteration of histone marks results in downregulation of the miRNA cluster. The regulation of miR-371-373 by SMAR1 inhibits breast cancer tumorigenesis and metastasis as determined by in vivo experiments. Overall, our study highlights the binding of SMAR1 to T(C/G) repeat and its role in cancer through miR-371-373.

References

  1. Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15819-24 - PubMed
  2. Cell. 2006 Mar 24;124(6):1169-81 - PubMed
  3. Mol Cell Biol. 1999 Feb;19(2):1279-88 - PubMed
  4. Nature. 1979 Dec 13;282(5740):680-6 - PubMed
  5. Nat Methods. 2012 Mar 04;9(4):357-9 - PubMed
  6. J Biol Chem. 2012 Aug 31;287(36):30641-52 - PubMed
  7. Gene. 2009 Dec 1;448(1):88-101 - PubMed
  8. Carcinogenesis. 2001 Feb;22(2):295-300 - PubMed
  9. Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3374-83 - PubMed
  10. Nucleic Acids Res. 2011 Jul;39(Web Server issue):W323-7 - PubMed
  11. J Biol Chem. 2005 Apr 22;280(16):16019-29 - PubMed
  12. Mol Oncol. 2012 Dec;6(6):590-610 - PubMed
  13. Stem Cells Dev. 2010 Jul;19(7):935-50 - PubMed
  14. Genome Res. 2002 Jun;12(6):996-1006 - PubMed
  15. Cell Death Dis. 2010 Nov 04;1:e94 - PubMed
  16. FEBS J. 2011 Jun;278(12):2044-54 - PubMed
  17. Oncogene. 2012 Jun 14;31(24):2968-78 - PubMed
  18. Mol Cell Biol. 2011 Jan;31(1):203-14 - PubMed
  19. BMC Bioinformatics. 2010 Aug 06;11:415 - PubMed
  20. BMC Bioinformatics. 2011 Dec 15;12:474 - PubMed
  21. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15557-62 - PubMed
  22. Oncogene. 2012 Jan 5;31(1):80-92 - PubMed
  23. Bioinformatics. 2009 Aug 15;25(16):2078-9 - PubMed
  24. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1608-13 - PubMed
  25. Mol Cell. 2010 May 28;38(4):576-89 - PubMed
  26. Nature. 2005 Jun 9;435(7043):745-6 - PubMed
  27. Nucleic Acids Res. 1990 May 25;18(10):3077-8 - PubMed
  28. Nucleic Acids Res. 2009 Jul;37(Web Server issue):W202-8 - PubMed
  29. Nat Cell Biol. 2008 Feb;10(2):202-10 - PubMed
  30. Nature. 1981 Dec 3;294(5840):417-22 - PubMed
  31. Genome Biol. 2008;9(9):R137 - PubMed
  32. Mol Cell Biol. 2005 Oct;25(19):8415-29 - PubMed
  33. EMBO J. 2010 Feb 17;29(4):830-42 - PubMed
  34. Nat Genet. 1992 Apr;1(1):45-9 - PubMed
  35. Int J Biochem Cell Biol. 2013 Nov;45(11):2519-29 - PubMed
  36. Cell Death Differ. 2013 Feb;20(2):367 - PubMed
  37. Int J Biochem Cell Biol. 2009 Apr;41(4):862-71 - PubMed
  38. Exp Cell Res. 2009 Sep 10;315(15):2529-38 - PubMed
  39. PLoS One. 2013 Dec 18;8(12):e82241 - PubMed
  40. PLoS One. 2014 Jul 09;9(7):e102117 - PubMed
  41. Nat Biotechnol. 2011 Jan;29(1):24-6 - PubMed
  42. PLoS One. 2007 Aug 01;2(7):e660 - PubMed
  43. Mol Genet Genomics. 2008 Apr;279(4):429-39 - PubMed
  44. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14753-8 - PubMed
  45. Mol Cancer. 2013 Apr 23;12:30 - PubMed
  46. PLoS One. 2014 Nov 20;9(11):e112930 - PubMed
  47. Int J Biochem Cell Biol. 2012 Jan;44(1):46-52 - PubMed
  48. Science. 2001 Oct 26;294(5543):853-8 - PubMed
  49. Oncotarget. 2015 Jun 20;6(17 ):15180-93 - PubMed
  50. Int J Clin Exp Pathol. 2009;2(4):361-9 - PubMed
  51. Nat Protoc. 2009;4(1):44-57 - PubMed
  52. EMBO J. 2002 Aug 1;21(15):4081-93 - PubMed
  53. Oncol Rep. 2011 Nov;26(5):1329-35 - PubMed
  54. PLoS Genet. 2006 Mar;2(3):e26 - PubMed
  55. Nat Commun. 2013;4:2724 - PubMed
  56. Mol Biol Rep. 2010 Oct;37(7):3553-60 - PubMed
  57. PLoS Genet. 2014 Feb 27;10(2):e1004177 - PubMed
  58. J Virol. 2000 Mar;74(6):2489-501 - PubMed
  59. PLoS Comput Biol. 2007 Mar 23;3(3):e39 - PubMed
  60. Development. 2005 Nov;132(21):4653-62 - PubMed

Publication Types